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Abstract X-linked agammaglobulinemia (XLA, OMIM#300300) is a rare monogenic primary
immunodeficiency caused by mutations in the Bruton tyrosine kinase (BTK) gene. XLA is
characterized by insufficient immunoglobulin levels and susceptibility to life-threatening
bacterial infections. We report on a patient that presented with ecthyma gangrenosum
and septicemia. Rapid trio whole-genome sequencing (rWGS) revealed an apparently de
novo hemizygous pathogenic variant (c.726dupT; p.Ile243TyrfsTer15) in the BTK gene.
Metagenomic analysis of rWGS sequences that did not align to the human genome re-
vealed 770 aligned to the Pseudomonas aeruginosa PAO1 genome. The patient was diag-
nosed with XLA and pseudomonal sepsis.
CASE PRESENTATION
A 19-mo-old twin Hispanic male was admitted to the hospital with fever (38.5°C) and com-
pensated septic shock. Physical examination revealed approximately one dozen deep, indu-
rated purpuric plaques with necrotic changes on the extremities and buttocks (Fig. 1). The
patient’s twin brother had died of septic shock, purpura fulminans, and disseminated intra-
vascular coagulation in an outside hospital 1 d prior, after a 2-d hospitalization for similar
symptoms. The twin brothers were born at 36-wk gestation and had not previously been hos-
pitalized, but the mother reported that for the past 8 mo they had been frequently ill with
respiratory tract infections requiringmultiple courses of antibiotics. At the time of admission,
the patient’s weight was 12 kg, which fell into the 70th percentile for age-matchedmale con-
trols. There was no family history of immunodeficiency.
Laboratory evaluation was significant for a white blood cell count of 2800 L−1 (reference
6000-14000) with 50% monocytes (2%–12%), 32% lymphocytes (30%–60%), 10% atypical
lymphocytes (0%–10%), 2% segmented neutrophils (45%–70%), and 7% band neutrophils
(0%–10%), C-reactive protein (CRP) level of 30.10 mg/dl (0.00–0.99), an erythrocyte
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sedimentation rate of 5 mm/h (0–10), procalcitonin level of 49.04 ng/ml (<2.0), prothrombin
time (PT) of 34.7 sec (11.4–14), and an international normalized ratio (INR) of 3.4 (0.9–1.2).
Immunoglobulin levels were IgG < 135 mg/dl (413–1112), IgA=32 mg/dl (21–117), and
IgM=19 mg/dl (30–146).
The patient was started on vancomycin, ceftriaxone, doxycycline, and gentamicin, as the
identity of the causative organism for this presumed community-acquired, life-threatening
infection was not initially known. Cultures from the patient’s blood were sterile. Filgrastim
(G-CSF) was also administered subcutaneously at a dose of 5 mcg/kg daily for an absolute
neutrophil count of 252 µl in the setting of overwhelming infection. Within the first 24 h of
admission, the patient required intubation for respiratory failure as well as vasopressor ther-
apy with multiple medications for fluid-refractory hypotension and poor perfusion. Because
of concerns about hypercoagulability, intravenous immunoglobulin (IVIG) was initially held,
but as the patient’s condition worsened, a dose of 0.4 mg/kg of IVIG was given, which in-
creased the patient’s IgG level to 646 mg/dl.
A tissue culture obtained from a 5-mm punch biopsy of a cutaneous lesion grew
Pseudomonas aeruginosa on the third hospital day. At that point, meropenem was add-
ed to the regimen and other antibiotics were eventually stopped. The diagnosis of pseu-
domonal ecthyma gangrenosum in this patient and the presumptive identical diagnosis
in his deceased twin brother were highly suspicious for a primary immune deficiency,
but the combination of neutropenia and low IgG and IgM levels did not conclusively
point to one diagnosis. A lymphocyte enumeration panel was sent and resulted a
CD19 absolute count of <20 cells/µl (830–1880) the following day, consistent with absent
B cells. Given the patient’s critically ill state and the recent death of his twin, rapid
trio whole-genome sequencing (rWGS) was undertaken simultaneously on the patient
and his parents. In just more than 72 h, on the fourth hospital day, an apparently de
novo hemizygous pathogenic variant (c.726dupT; p.Ile243TyrfsTer15; Table 1) in the
BTK gene was detected and the patient was diagnosed with X-linked agammaglobulin-
emia (XLA, OMIM#300300). As a result, filgrastim injections were discontinued and IVIG
was administered to maintain IgG levels of >800 mg/dl. On the same day (hospital day
4), verbal communication from the hospital where the patient’s brother expired con-
firmed a positive blood culture for pseudomonas in the deceased twin. The patient’s clin-
ical status and level of cardiorespiratory support slowly improved on anti-pseudomonal
antibiotics and IVIG therapy. He required regular debridement of the gangrenous lesions
by plastic surgery and eventually underwent skin grafting. He was discharged from the
hospital after a total of 5 mo.
B CA
Figure 1. Skin lesions in the affected patient showing (A) left hand, (B) left thigh, and (C ) right lower leg pseu-
domonal ecthyma gangrenosum.
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TECHNICAL ANALYSIS AND METHODS
The patient was enrolled in an IRB-approved research study. Blood was drawn immediately
followingconsent for trio rWGS.TheWGS testingwasperformed inaCAP/CLIAenvironment.
DNAwas subsequentlyextractedand sequencedonaHiSeq4000 (Illumina). Rapid alignment
and nucleotide variant calling was performed using the Dragen (Edico Genome) hardware
and software (Miller et al. 2015). Proband and parental samples were sequenced to a mean
coverage of 40×. Variants were annotated and analyzed in Opal Clinical (Fabric Genomics)
(Coonrod et al. 2013). Initially, variants were filtered to retain those with allele frequencies
of <1% in the Exome Variant Server, 1000 Genomes Samples, and Exome Aggregation
Consortium database (http://evs.gs.washington.edu/EVS/2016; Karczewski et al. 2017). A
gene panel was built in Phenolyzer (Yang et al. 2015) using Human Phenotype Ontology
(HPO) (Köhleret al. 2016). Thispanel included1098genes related to the followingHPOterms:
immunodeficiency (HP:0002721), neutropenia (HP:0001875), and sepsis (HP:0100806).
Variants were further filtered to retain thosemapping to these 1098 genes yielding 1068 pro-
band calls (465 homozygous variants, 509 heterozygous inherited variants, and 15 heterozy-
gous de novo variants). Manual curation revealed one variant as pathogenic by ACMG
guidelines (Richards et al. 2015). Specifically, the criteria invoked to score this variant as path-
ogenic included PVS1 (null variant in a gene where loss of function is a known mechanism of
disease), PS2 (de novovariant), andPM2 (variant is absent fromcontrols). This variantwas con-
firmed by Sanger sequencing. The diagnosis was made by rWGS in 4 d.
VARIANT INTERPRETATION
This patient was found to be hemizygous for an apparently de novo known pathogenic
frameshift variant (c.726dupT; p.Ile243TyrfsTer15) in the Bruton tyrosine kinase (BTK)
gene. Pathogenic variants in BTK have been implicated in XLA (OMIM#300300).
The de novo p.Ile243TyrfsTer15 pathogenic variant has been previously reported in a
single individual with XLA (Holinski-Feder et al. 1998). p.Ile243TyrfsTer15 is absent from
the ExAC and gnomAD population databases. The deletion causes a frameshift starting
with codon Isoleucine 243, changes this amino acid to a tyrosine residue, and creates a
premature stop codon at position 15 of the new reading frame. This pathogenic variant is
predicted to cause loss of normal protein function through protein truncation or non-
sense-mediated decay of the mRNA transcript.
METAGENOMICS
Per institutional protocol, samples were processed via a standard clinically validated work-
flow, in addition to passing a battery of quality control (QC) scripts (Farnaes et al. 2018).
Table 1. Genomic findings
Gene
Genomic
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Using the reference human genome hg37dh, the QC metric of percent aligned reads
passed at 98.8% and did not have a statistically significant deviation from median of past
samples (N=100). Given the pseudomonas sepsis phenotype, a metagenomics exploration
was performed: After isolating the unaligned portion of reads, the most frequent, randomly
sampled 500 reads were checked against the NCBI NR database, and significant similarity to
P. aeruginosa genome was noted, whereas similarity to other pathogenic or nonpathogenic
genomes was not found. The random sampling was drawn from the 500 most abundant
reads (including duplicates). Then, all unaligned reads were aligned to reference P. aerugi-
nosa PAO1 genome and 770 paired reads (654 unique; duplication rate 14%) were aligned.
The qualities of the PAO1-aligned reads were not significantly different from those that
aligned to the reference human genome (mean Q in read 1=36.28 and in read 2=36.04,
aligned to PAO1; mean Q in read 1=36.09 and in read 2=35.66, aligned to hg19). For neg-
ative controls, unaligned portions of the patient’s parental genomic DNA as well as genomic
DNA from five random, unrelated persons were aligned to the reference PAO1 genome and
0–3 paired reads aligned in each (establishing the level of random alignments). Furthermore,
the pattern of spatial distribution of the 770 reads from the proband’s DNA sample to PAO1
genome was nearly uniform over the full length of the PAO1 genome (6.2 Mb, 25±10 reads
in each 200 kb window, i.e., ∼1 read/8 kb), resulting in the conclusion of the bona fide low-
titer presence of P. aeruginosa in the proband’s DNA sample (Fig. 2).
DISCUSSION
Inherited defects of the immune system have an incidence of nearly 1 in 2000 children
(Bonilla et al. 2015). More than 300 primary immunodeficiencies (PIDs) are currently known,
with the list rapidly expanding (Bonilla et al. 2015; Picard et al. 2015). Between 2013 and
2015 alone, 34 new gene defects for PID were identified (Picard et al. 2015). The severity
of infection in affected patients encompasses a spectrum ranging from recurrent respiratory
illnesses to life-threatening systemic disease. Current consensus guidelines advocate for a
stepwise approach to identifying a suspected PID (Bonilla et al. 2015). However, identifying
specific immunodeficiencies in this manner can take weeks to months and delay in diagnosis
is significantly associated with increased mortality in these patients (Joshi et al. 2009). More
Figure 2. Uniformly random spatial distribution of 770 reads from the proband’s DNA sample (in which the y-
axis represents the number of reads) aligned to the PAO1 genome (in which the x-axis is position Mb of the
PAO1 genome; total size=6.2 Mb).
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recently, whole-exome sequencing has started to be explored as a high-throughput ap-
proach to diagnosing patients with suspected PIDs, with a diagnostic rate of up to 40%
(Stray-Pedersen et al. 2017). rWGS is emerging as a technology capable of making a specific
genetic diagnosis in time to effect changes in acute clinical management. In our patient, the
diagnosis of XLAwas highly likely after the lymphocyte enumeration panel demonstrated ab-
sent B cells, and the next traditional step in the absence of rWGS would be to sequence the
suspected gene (in this case, BTK), which takes several weeks to result. rWGS was able to
make the diagnosis of XLA within 74.5 h.
XLA is a primary humoral immunodeficiency typically characterized by severe hypogam-
maglobinemia and recurrent bacterial infections (Smith and Berglöf 2016). It is caused by
mutations in BTK, which encodes Bruton tyrosine kinase (Btk) (Smith and Berglöf 2016).
Btk is a signal transduction molecule essential to B-cell lineage development, and its loss im-
pairs the progression of pre-B cells to mature lymphocytes (Ochs and Smith 1996). The lack
of mature B lymphocytes results in insufficient immunoglobulin levels, and affected patients
are unable to mount an appropriate antibody response to infection. Affected persons have
normal levels of IgG at birth because of transplacental passage of maternal immunoglobulin,
but become susceptible to bacterial and enteroviral infections as these levels gradually wane
during the first year of life (Ochs and Smith 1996). The diagnosis of XLA is suspected when
laboratory investigations demonstrate absent B cells and a reduction in all classes of immu-
noglobulins, and it is confirmed by identifying a pathogenic variant in BTK (Ochs and Smith
1996; Smith and Berglöf 2016).
The bacterial infections responsible for causing severe disease in patients with XLA are
most frequently the pyogenic organisms Streptococcus pneumoniae and Hemophilus influ-
enzae (Zenone and Souillet 1996; Winkelstein et al. 2006). Although uncommon, in addition
to our patient there have been case reports of patients presenting with P. aeruginosa septi-
cemia and ecthyma gangrenosum that were subsequently diagnosedwith XLA (Nussinovitch
et al. 1991; Zenone and Souillet 1996).
The diagnosis of XLA by rWGS explained the patient’s susceptibility to pseudomonal
sepsis, indicated the appropriate management to be regular IVIG infusions, and may have
prevented additional life-threatening infections. Retrospectively, it also provided an expla-
nation for the death of his twin brother. The patient will be closely followed by immunology
for the duration of his lifetime. In addition to monthly IVIG infusions, the patient will have to
avoid live vaccinations and his treating physicians should have a low threshold for initiating
antibiotic therapy when he is ill.
The metagenomic analysis identification of 770 P. aeruginosa genome sequences con-
firmed the presence of the bacterial DNA in the patient’s bloodstream (DNAemia) and the
clinical diagnosis of severe sepsis. Blood cultures in our patient, while receiving broad spec-
trum antibiotics, never grew Pseudomonas, and the bacterium was identified by culture of a
skin biopsy of one of the gangrenous lesions. Patients with bacterial sepsis infrequently have
skin lesions available for biopsy—in the absence of that sample for this patient, nucleic acid
analysis would potentially have been the only acute method for identifying the responsible
bacterial agent. This raises the possibility that rWGS could potentially have utility in identi-
fication of disease-causing organisms, especially in cases of culture-negative sepsis, andwar-
rants further exploration.
SUMMARY
We report on a case of XLA presenting as pseudomonal ecthyma gangrenosum and severe
sepsis that was diagnosed expeditiously by rWGS. rWGS identified a de novo frameshift
variant (c.726dupT; p.Ile243TyrfsTer15) in BTK, the Bruton tyrosine kinase gene on
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Chromosome X. Thus, the proband was determined to be hemizygous for the monogenic
disorder XLA. Additionally, metagenomic analysis of rWGS sequences that did not align
to the human genome were found to align to the P. aeruginosa PAO1 genome.
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